Lack of effect of a bisphosphonate (Pamidronate disodium) infusion on subsequent skeletal uptake of Sm-153 EDTMP

Clinical Nuclear Medicine

Volumn 27, Issue 6, 2002, Pages 427-430

  Marcus, Carol S ^a   Saeed, Sohail ^a   Mlikotich, Anton ^a   Mishkin, Fred ^a   Pham, H Lee ^a   Javellana, Theodomyllar ^a   Diestelhorst, Saeda ^a   Minami, Craig ^a  

^a NONE   (United States)

Author keywords

Bisphosphonate; Pamidronate Disodium; Sm 153 EDTMP

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; LEXIDRONAM SAMARIUM SM 153; PAMIDRONIC ACID;

ARTICLE; BONE METASTASIS; BREAST CANCER; CASE REPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG UPTAKE; HUMAN; IMAGE ANALYSIS; SKELETON; TISSUE DISTRIBUTION; WHOLE BODY SCINTISCANNING;

BONE AND BONES; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; RADIOISOTOPES; TIME FACTORS; WHOLE-BODY COUNTING;

EID: 0036100542     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200206000-00008     Document Type: Article

References (9)

1. Alendronate does not interfere with Tc-99m-methylene diphosphonate bone scanning
2. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy
3. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone
4. Effects of clodronate treatment on bone scintigraphy in metastatic breast cancer
5. The bisphosphonate dilemma
6. Intravenous aminohydroxypropylidene bisphosphonate does not modify Tc-99m-hydroxymethylene bisphosphonate bone scintigraphy: A prospective study
7. Bisphosphonate effect on bone scintigraphy